KIAA1549
Basic information
Region (hg38): 7:138831381-138981389
Links
Phenotypes
GenCC
Source:
- retinitis pigmentosa 86 (Moderate), mode of inheritance: AR
- retinitis pigmentosa (Supportive), mode of inheritance: AD
- retinitis pigmentosa 86 (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Retinitis pigmentosa 86 | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Ophthalmologic | 30120214 |
ClinVar
This is a list of variants' phenotypes submitted to
- Retinitis pigmentosa 86 (2 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the KIAA1549 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 14 | 408 | 32 | 454 | ||
missense | 730 | 30 | 26 | 786 | ||
nonsense | 4 | |||||
start loss | 1 | |||||
frameshift | 13 | |||||
inframe indel | 9 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 12 | 15 | 1 | 28 | ||
non coding | 62 | 71 | ||||
Total | 2 | 3 | 768 | 500 | 66 |
Variants in KIAA1549
This is a list of pathogenic ClinVar variants found in the KIAA1549 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
7-138837915-G-A | Likely benign (Aug 16, 2022) | |||
7-138837918-G-C | Uncertain significance (Apr 21, 2022) | |||
7-138837926-C-T | Inborn genetic diseases • Retinal dystrophy | Uncertain significance (Oct 01, 2023) | ||
7-138837927-G-A | Likely benign (Dec 17, 2023) | |||
7-138837928-G-A | Uncertain significance (Jun 20, 2021) | |||
7-138837933-C-G | Inborn genetic diseases | Uncertain significance (Oct 06, 2023) | ||
7-138837937-T-C | Uncertain significance (Nov 08, 2022) | |||
7-138837940-T-C | Uncertain significance (Oct 13, 2022) | |||
7-138837944-A-C | Uncertain significance (Oct 03, 2023) | |||
7-138837945-G-A | Likely benign (Jun 26, 2021) | |||
7-138837949-C-T | Uncertain significance (Aug 09, 2022) | |||
7-138837950-G-A | Inborn genetic diseases | Uncertain significance (Nov 27, 2023) | ||
7-138837963-G-A | Likely benign (Jan 18, 2024) | |||
7-138837963-G-T | Likely benign (Nov 13, 2023) | |||
7-138837964-C-T | Uncertain significance (Feb 23, 2022) | |||
7-138837965-G-A | Uncertain significance (Oct 08, 2021) | |||
7-138837978-G-T | Likely benign (Jan 18, 2023) | |||
7-138837980-G-C | Inborn genetic diseases | Uncertain significance (Nov 12, 2021) | ||
7-138837981-A-G | Likely benign (Jul 13, 2022) | |||
7-138837984-G-A | Likely benign (Jul 18, 2022) | |||
7-138837987-C-T | Uncertain significance (Apr 08, 2021) | |||
7-138837988-G-A | Inborn genetic diseases | Uncertain significance (Nov 09, 2021) | ||
7-138837991-G-A | Uncertain significance (Feb 17, 2022) | |||
7-138837994-T-C | Uncertain significance (May 22, 2023) | |||
7-138837995-G-T | Uncertain significance (Nov 25, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
KIAA1549 | protein_coding | protein_coding | ENST00000422774 | 20 | 149939 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.986 | 0.0139 | 124645 | 0 | 29 | 124674 | 0.000116 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.0923 | 1121 | 1.11e+3 | 1.01 | 0.0000698 | 12426 |
Missense in Polyphen | 388 | 445.27 | 0.87137 | 4725 | ||
Synonymous | -1.23 | 525 | 490 | 1.07 | 0.0000360 | 4249 |
Loss of Function | 6.15 | 12 | 65.9 | 0.182 | 0.00000351 | 779 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000581 | 0.0000581 |
Ashkenazi Jewish | 0.000300 | 0.000298 |
East Asian | 0.000223 | 0.000223 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000144 | 0.000142 |
Middle Eastern | 0.000223 | 0.000223 |
South Asian | 0.000131 | 0.000131 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Disease
- DISEASE: Note=A chromosomal aberration involving KIAA1549 is found in pilocytic astrocytoma. A tandem duplication of 2 Mb at 7q34 leads to the expression of a KIAA1549-BRAF fusion protein with a constitutive kinase activity and inducing cell transformation. {ECO:0000269|PubMed:18974108}.;
- Pathway
- Disease;Signaling by BRAF and RAF fusions;Oncogenic MAPK signaling;Diseases of signal transduction
(Consensus)
Recessive Scores
- pRec
- 0.104
Intolerance Scores
- loftool
- 0.494
- rvis_EVS
- 1.66
- rvis_percentile_EVS
- 96.24
Haploinsufficiency Scores
- pHI
- 0.460
- hipred
- N
- hipred_score
- 0.270
- ghis
- 0.383
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0789
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | High | High | High |
Primary Immunodeficiency | High | High | High |
Cancer | High | High | High |
Mouse Genome Informatics
- Gene name
- D630045J12Rik
- Phenotype
- adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); immune system phenotype; homeostasis/metabolism phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);
Gene ontology
- Biological process
- regulation of transcription by RNA polymerase II
- Cellular component
- plasma membrane;integral component of membrane
- Molecular function
- DNA-binding transcription factor activity, RNA polymerase II-specific